** Mondelez International MDLZ.O topped Wall St estimates for Q2 revenue and profit, driven by strong global demand for its premium chocolates and biscuits, especially in Europe
** Shares down around 2% at $68.34 with low volumes in pre-market trading
STICKY SITUATIONS AND SWEET SPOTS
** Bernstein ("outperform," PT: $88) says 2026 outlook appears promising, on expectations of easing cocoa costs, strong emerging market performance, and resilient chocolate demand outside the U.S. despite potential GLP-1 drug-related drags on consumer demand
** BofA ("buy," PT: $75) says "we view MDLZ's quarter as a standout relative to both multi-national & packaged food peers given strength in organic sales & execution"
** Piper Sandler ("neutral," PT: $67) says cocoa is the "key building block for 2026 EPS growth," citing strong pricing power in Europe, while flagging risks from potential tariff changes and macroeconomic uncertainty
** TD Cowen ("buy," PT: $75) says co's 2026 outlook reflects uncertainty around cocoa costs and volume recovery, keeping the stock range-bound for now
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.